Novavax Inc Capital Reinvestment Ratio
Novavax Inc capital reinvestment ratio. Novavax Inc (NVAX) has a Capital Reinvestment Ratio of 0.02x as of September 2025, meaning it reinvests 0% of its operating cash flow ($107.80 Million) in capital expenditures ($2.02 Million). Check NVAX total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Novavax Inc (2021–2021)
Capital reinvestment ratio of Novavax Inc from 2021 to 2021. This chart tracks Novavax Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore NVAX year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Novavax Inc Capital Reinvestment Ratio by Year (2021–2021)
Novavax Inc capital reinvestment ratio by year from 2021 to 2021. For the full cash flow conversion analysis, see Novavax Inc (NVAX) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.18x | $322.95 Million | $57.49 Million | — |